Haemophilia: open trials in Germany

29 open trials have a site in Germany. Registry data; only the trial team decides who can take part.

NCT07416604
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
Trial Treatment · Phase 3 · Hoffmann-La Roche
Vivantes Netzwerk fuer Gesundheit GmbH, Berlin · Universitaetsklinikum Bonn AöR, Bonn · Goethe University Frankfurt, Frankfurt Am Main · Medical Center- University of Freiburg, Freiburg im Breisgau · University Medical Center Hamburg-Eppendorf, Hamburg · Medizinische Hochschule Hannover, Hanover
Registry updated 2026-11-03
NCT07830732
A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A
Trial Treatment · Phase 3 · Novo Nordisk A/S
Vivantes Netzwerk fuer Gesundheit GmbH, Berlin · Universitaetsklinikum Bonn AöR, Bonn · Medizinische Hochschule Hannover, Hanover · Universitaetsklinikum Leipzig Aor, Leipzig · Universitaetsklinikum Regensburg AöR, Regensburg
Registry updated 2026-10-28
2025-523896-44-00
Efanesoctocog alfa treatment in patients with congenital hemophilia A suffering from inflammation of joint lining
Trial Treatment · Phase 3 · GWT-Tud GmbH
Vivantes Netzwerk fuer Gesundheit GmbH, Berlin · Universitaetsklinikum Bonn AöR, Bonn · Technische Universitaet Dresden, Dresden · Gerinnungszentrum Rhein-Ruhr Aerztepartnerschaft Dr. med. Hannelore Rott Fachaerztin fuer Transfusionsmedizin Haemostaseologie Dr. med. Susan Halimeh Fachaerztin fuer Transfusionsmedizin Haemostaseologie Dr. med. Guenther Kappert Facharzt fuer Laboratoriumsmedizin Haemostaseologie, Duisburg · HZRM Haemophilie-Zentrum Rhein Main GmbH, Frankfurt am Main · Universitaetsklinikum Frankfurt AöR, Frankfurt Am Main · Justus-Liebig-Universitaet Giessen, Giessen · University Medical Center Hamburg-Eppendorf, Hamburg · Medizinische Hochschule Hannover, Hanover · Universitaetsklinikum des Saarlandes AöR, Homburg · Universitaetsklinikum Schleswig-Holstein AöR, Kiel · Universitaetsklinikum Leipzig Aor, Leipzig · Universitaetsklinikum Regensburg AöR, Regensburg
Registry updated 2026-10-27
NCT07285460
A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
Trial Treatment · Phase 3 · Sanofi
Ludwig-Maximilians-Universitaet Muenchen, Munich
Registry updated 2026-10-27
NCT05145127
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Trial Treatment · Phase 3 · Pfizer
Charité Campus Virchow-Klinikum, Berlin
Registry updated 2026-10-26
NCT07416526
A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
Trial Treatment · Phase 3 · Hoffmann-La Roche
Vivantes Netzwerk fuer Gesundheit GmbH, Berlin · Universitaetsklinikum Bonn AöR, Bonn · Goethe University Frankfurt, Frankfurt Am Main · Medical Center- University of Freiburg, Freiburg im Breisgau · Medizinische Hochschule Hannover, Hanover
Registry updated 2026-10-26
2025-523660-21-00
A Non-Investigational Product, Multi-Center Cohort Study to Describe Long-Term Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec
Trial Treatment · Phase 3 · Pfizer Inc.
Vivantes Klinikum Friedrichshain, Berlin · Universitätsklinikum Bonn, Bonn
Registry updated 2026-10-23
NCT06379789
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
Trial Treatment · Phase 1/2 · Regeneron Pharmaceuticals
Universitaetsklinikum Bonn AöR, Bonn · Universitaetsklinikum Frankfurt AöR, Frankfurt Am Main · University Medical Center Hamburg-Eppendorf, Hamburg
Registry updated 2026-10-21
NCT05611801
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
Trial Treatment · Phase 3 · Pfizer
Charite Universitatsmedizin Berlin KöR, Berlin
Registry updated 2026-10-14
NCT05568719
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
Trial Treatment · Phase 3 · Pfizer
Universitätsklinikum Bonn, Bonn
Registry updated 2026-10-07
NCT07653139
Patient Preferences in Treatment of Haemophilia A With and Without Inhibitors: a Discrete Choice Experiment in Germany
Research · Novo Nordisk A/S
Mainz
Registry updated 2026-10-06
NCT04023019
Treatment of Hemophilia A Patients With FVIII Inhibitors
Research · Phase 4 · Emory University
Universitaetsklinikum Bonn AöR, Bonn · Gerinnungszentrum Rhein-Ruhr Aerztepartnerschaft Dr. med. Hannelore Rott Fachaerztin fuer Transfusionsmedizin Haemostaseologie Dr. med. Susan Halimeh Fachaerztin fuer Transfusionsmedizin Haemostaseologie Dr. med. Guenther Kappert Facharzt fuer Laboratoriumsmedizin Haemostaseologie, Duisburg · HZRM Haemophilie-Zentrum Rhein Main GmbH, Frankfurt am Main · Justus-Liebig-Universitaet Giessen, Giessen · Universitaetsklinikum Muenster AöR, Muenster
Registry updated 2026-09-23
NCT07220564
A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Trial Treatment · Phase 1 · Novo Nordisk A/S
Vivantes Netzwerk fuer Gesundheit GmbH, Berlin · Universitaetsklinikum Bonn AöR, Bonn · Medizinische Hochschule Hannover, Hanover
Registry updated 2026-09-18
2022-502061-17-00
Nuwiq Dosing and outcomes In the ManagEment of women/girls with haemophilia A Needing FVIII treatment for Surgery – an International, Open-label, Non-controlled study (NuDIMENSION)
Trial Treatment · Phase 4 · Octapharma AG
Universitaetsklinikum Bonn AöR, Bonn · University Medical Center Hamburg-Eppendorf, Hamburg
Registry updated 2026-07-10
NCT03745924
A Study Following Males With Haemophilia B on Prophylaxis With Refixia/REBINYN
Research · Novo Nordisk A/S
Vivantes Netzwerk für Gesundheit GmbH - Vivantes Klinikum im Friedrichshain, Berlin · Universitätsklinikum Bonn - Institut für Experimentelle Hämatologie, Bonn
Registry updated 2026-06-12
NCT03695978
Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
Research · Octapharma
Vivantes - Netzwerk für Gesundheit GmbH Klinikum im Friedrichshain, Berlin · Institute of Experimental Haematology and Transfusion Medicine (IHT) University Clinic Bonn (AöR), Bonn · Coagulation Research Centre GmbH, Duisburg · University Hospital Essen, Essen · HZRM GmbH, Frankfurt
Registry updated 2026-06-02
NCT05935358
Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
Trial Treatment · Phase 4 · Octapharma
Vivantes Klinikum im Friedrichshein (KFH), Berlin · Gerinnungszentrum Rhein-Ruhr, Duisburg · Universitatsklinikum Hamburg-Eppendorf (UKE), Hamburg
Registry updated 2026-05-12
NCT05936580
Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
Trial Treatment · Phase 4 · Octapharma
Universitätsklinikum Bonn,Institut für Experimentelle Haematologie und Transfusionsmedizin, Bonn · Gerinnungszentrum Rhein-Ruhr, Duisburg · Universitätsklinikum Hamburg Eppendorf - II Medizinische Klinik und Poliklinik, Hamburg
Registry updated 2026-05-12
NCT02207894
A Survey on the Success of Inhibitor Elimination Using Individualized Concentrate Selection and Controlled ITI
Research · Haemophilia Centre Rhine Main
Haemophilia Centre Rhine Main, Frankfurt am Main
Registry updated 2026-04-21
NCT06008938
An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B
Research · CSL Behring
Klinik für Angiologie/ Hämostaseologie, Berlin · University of Clinic Bonn, Bonn · Klinikum der Johann Wolfgang Goethe-Universitaet, Frankfurt · Hannover Medical School, Hanover
Registry updated 2026-02-19
NCT05768386
A Long-Term Follow-Up Study in Severe Hemophilia A Subjects Who Received BMN 270 in a Prior BioMarin Clinical Trial (270-401)
Research · Phase 4 · BioMarin Pharmaceutical
Vivantes Netzwerk fuer Gesundheit GmbH, Berlin · Universitaetsklinikum Bonn AöR, Bonn
Registry updated 2026-01-12
NCT04574076
A Study Following Males With Haemophilia A on Prophylaxis With Esperoct®
Research · Novo Nordisk A/S
Vivantes Netzwerk für Gesundheit GmbH - Vivantes Klinikum im Friedrichshain, Berlin · Universitätsklinikum Bonn - Institut für Experimentelle Hämatologie, Bonn
Registry updated 2025-12-22
NCT07259356
Feasibility and Safety of Blood-Flow-Restriction Training in Patients With Hemophilia
Trial Treatment · University Hospital, Bonn
University Hospital Bonn, Bonn
Registry updated 2025-12-02
2022-502060-21-00
Nuwiq for Perioperative management Of patients With haemophilia A on Emicizumab Regular prophylaxis study (NuPOWER)
Trial Treatment · Phase 4 · Octapharma AG
Vivantes Netzwerk fuer Gesundheit GmbH, Berlin · University Medical Center Hamburg-Eppendorf, Hamburg
Registry updated 2025-09-25
NCT02979119
The European Paediatric Network for Haemophilia Management ( PedNet Registry)
Research · PedNet Haemophilia Research Foundation
Charité Campus Virchow Klinikum, Klinik für Pädiatrie m.S. Onkologie und Hämatologie, Berlin · Department of Internal Medicine, Hemophilia Treatment Center, Vivantes Klinikum im Friedrichshain, Berlin · Institut für Experimentelle Hämatologie und Transfusionsmedizin Universitätsklinikum Bonn, Bonn · Klinik Bremen-Mitte Prof.-Hess-Kinderklinik, Bremen · Hämophilie Zentrum Rhein Main, Frankfurt · University Hospital Frankfurt & Goethe University - Clinical and Molecular Hemostasis, Department of Pediatrics, Frankfurt am Main · Dr. v. Haunersches Kinderspital University of Munich, Munich
Registry updated 2025-09-16

All Haemophilia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error